TALL-104細胞 
	
		數量:	大量
	
	
		年限:	2 years
	
	
		細胞類型:	T**細胞
	
	
		是否是腫瘤細胞:	0
	
	
		物種來源:	人
	
	
		生長狀態:	懸浮生長
	
	
		運輸方式:	凍存運輸
	
	
		ATCC Number:	CRL-11386?
	
	
		相關**:	白血病
	
	
		細胞形態:	**樣
	
	
		Designations:	TALL-104
	
	
		Depositors:	 Wistar Institute
	
	
		Biosafety Level:	1
	
	
		TALL-104細胞Shipped:	frozen
	
	
		Medium & Serum:	See Propagation
	
	
		Growth Properties:	suspension
	
	
		Organism:	Homo sapiens
	
	
		Morphology:	lymphoblast
	
	
		
	
	
		Source:	Disease: acute lymphoblastic leukemia
	
	
		Cell Type: T lymphoblast;
	
	
		Cellular Products:	interferon gamma (IFN gamma); tumor necrosis factor alpha (TNF alpha); granulocyte monocyte colony stimulating factor (GM-CSF)
	
	
		Permits/Forms:	In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
	
	
		Receptors:	T cell antigen receptor alpha/beta (TCR), expressed
	
	
		interleukin 2 (IL-2), expressed
	
	
		interleukin 2 (IL-2); T cell antigen receptor alpha/beta (TCR)
	
	
		Antigen Expression:	CD2 +; CD3 +; CD7 +; CD8 +; CD56 +; CD4 -; CD16 -
	
	
		DNA Profile (STR):	Amelogenin: X,Y
	
	
		CSF1PO: 10,11
	
	
		D13S317: 9,12
	
	
		D16S539: 12
	
	
		D5S818: 12,13
	
	
		TALL-104細胞D7S820: 7,13
	
	
		THO1: 7,9
	
	
		TPOX: 8,9
	
	
		vWA: 14,18
	
	
		Cytogenetic Analysis:	46, XY; t(11;14)(p13;q11)
	
	
		Age:	2 years
	
	
		Gender:	male
	
	
		Comments:	The TALL-104 line was established from the peripheral blood of a child in relapse with T-ALL.
	
	
		The cells are highly cytotoxic and are capable of tumor destruction in vivo and in vitro.
	
	
		IL-2 is required from optimal growth and long term cultivation, but the cells can be grown for short periods without IL-2 (growth will be slower).
	
	
		The cells are positive for the alpha/beta TCR and negative for gamma/delta TCR.
	
	
		Propagation:	ATCC complete growth medium: The base medium for this cell line is ATCC-formulated Iscove's Modified Dulbecco's Medium, Catalog No. ATCC 30-2005. To make the complete growth medium, add the following components to the base medium: 50 to 100 units/ml recombinant human IL-2; 2.5 microgram/ml human albumin; 0.5 microgram/ml D-mannitol; fetal bovine serum to a final concentration of 20%.
	
	
		Atmosphere: air, 95%; TALL-104細胞carbon dioxide (CO2), 5%
	
	
		Temperature: 37.0°C
	
	
		Growth Conditions: Successful growth of this cell line is very dependent upon the quality of IL-2 used in the growth medium. ATCC recommends using the highest quality IL-2 available.
	
	
		Subculturing:	Protocol: Cultures can be maintained by addition or replacement of fresh medium. Start cultures at least 8 X 10(5) cells/ml.
	
	
		Note: IL-2 rapidly loses its potency in medium, it is important that fresh IL-2 be used.
	
	
		Interval: Maintain between 4 X 10(5) and 1 X 10(6) cells/ml.
	
	
		Medium Renewal: Add medium as cell density increases
	
	
		Preservation:	Freeze medium: Complete growth medium supplemented with 50% fetal bovine serum, and 10% DMSO. Freeze at a cell density of at least 15 X 10(6) cells/ml
	
	
		Storage temperature: liquid nitrogen vapor phase
	
	
		References:	22047: TALL-104細胞Santoli D, et al. Cytotoxic T-ALL cell lines and uses therefor. US Patent 5,272,082 dated Dec 21 1993
	
	
		23356: O'Connor R, et al. Growth factor requirements of childhood acute T-lymphoblastic leukemia: correlation between presence of chromosomal abnormalities and ability to grow permanently in vitro. Blood 77: 1534-1545, 1991. PubMed: 1706955
	
	
		23357: Cesano A, et al. Homing and progression patterns of childhood acute lymphoblastic leukemias in severe combined immunodeficiency mice. Blood 77: 2463-2474, 1991. PubMed: 2039829